MRNA Past Earnings image   This MRNA past earnings page last updated 8/5/2022
MRNA Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/3/20225.240
Q1 20225/4/20228.580
Q4 20212/24/202211.290
Q3 202111/4/20217.700
Q2 20218/5/20216.460
Q1 20215/6/20212.840
Q4 20202/25/2021-0.690
Q3 202010/29/2020-0.590
Q2 20208/5/2020-0.310
Q1 20205/7/2020-0.350
Q4 20192/26/2020-0.370
Q3 201911/6/2019-0.370
Q2 20198/7/2019-0.410
Q1 20195/8/2019-0.400
Q4 20183/6/2019-0.43
MRNA Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/3/20224.75B
Q1 20225/4/20226.07B
Q4 20212/24/20227.21B
Q3 202111/4/20214.97B
Q2 20218/5/20214.35B
Q1 20215/6/20211.94B
Q4 20202/25/20210.57B
Q3 202010/29/20200.16B
Q2 20208/5/20200.07B
Q1 20205/7/20200.01B
Q4 20192/26/20200.01B
Q3 201911/6/20190.02B
Q2 20198/7/20190.01B
Q1 20195/8/20190.02B
Q4 20183/6/201935.42M
Quotes delayed 20 minutes

Email EnvelopeFree MRNA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Moderna (MRNA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

MRNS Past Earnings
MRSN Past Earnings
MRTX Past Earnings
MRVI Past Earnings
MSON Past Earnings
MTCR Past Earnings
MTEM Past Earnings
MXCT Past Earnings
MYGN Past Earnings
MYMD Past Earnings

MRNA Past Earnings Q&A

What was the best and worst MRNA past earnings results?
For Moderna, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest MRNA past earnings result in our data set was 11.290/share posted in Q4 2021, while the lowest was in Q4 2020 when MRNA posted -0.690/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when MRNA reported 7.21B in revenue, while the quarter with the lowest revenue in our data set was Q1 2020 at 0.01B of revenue.

  Suggested answer: There are 15 MRNA past earnings results in our data set.

On this page we presented the MRNA past earnings date information for Moderna. Reviewing that MRNA Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when MRNA posted gaap of 11.290/share. Meanwhile the lowest MRNA past earnings result was in Q4 2020, when MRNA posted gaap of -0.690/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when MRNA reported 7.21B in revenue, while the smallest revenue quarter was Q1 2020 when MRNA reported 0.01B in revenue.

Any self directed investor doing their due diligence on MRNA or any other given stock can benefit from researching all of the Moderna past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Moderna past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MRNA. Thanks for visiting, and the next time you need to research MRNA past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Howmet Aerospace DMA, Top Ten Hedge Funds Holding GOOS, AEY Insider Buying.

 

MRNA Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.